Cervical screening programme: HPV triage and test of cure protocol

Testing for high-risk human papillomavirus (HR-HPV) as triage and test of cure was introduced into the Northern Ireland Cervical Screening Programme on Monday 28 January 2013. This policy change will significantly alter the screening pathway for women with a mild dyskaryosis or borderline smear result. The link between HR-HPV infection and the development of cervical cancer has now been clearly established, with almost 100% of cervical cancers containing HPV DNA. Women with no evidence of HR-HPV infection are extremely unlikely to develop cervical cancer in the short to medium term. HPV triage is the process whereby HR-HPV testing is used to manage women with low grade cervical abnormalities. Only 15-20% of women with a borderline or mild smear result have a significant abnormality that needs treatment. HR-HPV testing is effective in identifying which women may need treatment and allows colposcopy resources to be allocated more effectively.The test of cure process is being introduced because it is now known that women with a normal or low grade smear test, and who are HR-HPV negative at six months after treatment, are at very low risk of residual disease. These women do not need to be recalled for another screening appointment for three years.The test of cure process means all post-treatment smears (at six months) that are reported as normal, borderline or mild dyskaryosis will be tested for HR-HPV. Those women who are HR-HPV positive will remain at colposcopy. HR-HPV negative women can be safely returned to recall in three years. It is estimated that the HR-HPV test of cure will allow approximately 80% of women who have been through treatment to avoid undergoing annual smear tests. This flowchart poster outlines the new triage and test of cure process. It was distributed to all GPs in Northern Ireland and is available to download as a PDF from this website.�

Screening patients for Pseudomonas - Parent/Carer Information leaflet

Information leaflet for parents and carers on screening patients for Pseudomonas.

AAA screening programme wallet card

This wallet card has been produced to help maximise awareness of the abdominal aortic aneurysm (AAA) screening programme in Northern Ireland. It provides the website address of the screening programme - www.aaascreening.info - as well as email and telephone contact details for the screening programme office. A postal address is also included. The wallet cards will be distributed to eligible men through the following channels, among others: public events, eg talks with men's groups, Farm Families Health Checks programme;health information stands in shopping centres, supermarkets etc;GP practices;pharmacies. �

Abdominal Aortic Aneurysm (AAA) Screening Programme annual report

This inaugural annual report for the Northern Ireland Abdominal Aortic Aneurysm (AAA) Screening Programme (produced jointly by the Public Health Agency and the Belfast Health and Social Care Trust) looks back on a successful first year for the programme. The Public Health Agency (PHA) is responsible for commissioning and quality assuring the programme. The Belfast Health and Social Care Trust is responsible for providing and managing the programme.Following significant planning, AAA screening was introduced on time in June 2012, as required by the Government's 'Priorities for Action' target. There is no doubt that this was due to sustained partnership working across a wide range of health and social care services within Northern Ireland.

Northern Ireland cervical screening programme: information for primary care and smear takers

From January 2011, the Northern Ireland cervical screening programme no longer invited women aged under 25 to attend for screening. In addition, the screening interval for women aged 25-49 was reduced to every three years.This�booklet describes the rationale for the change in policy so that primary care staff and smear takers can provide appropriate and accurate advice to patients.

Northern Ireland Diabetic Retinopathy Screening Programme

As you have diabetes, your GP has arranged foryou to attend the Diabetic Retinopathy Screening Programme. This service is free and is provided aspart of your diabetes care.

Breast screening: why have I been called back? (English and translations)

This leaflet is used to support the Northern Ireland breast screening programme and explains the additional tests that may be offered at a breast assessment clinic following a mammogram that has shown a possible abnormality�

Northern Ireland breast screening: Helping you decide (English and 12 translations)

This leaflet is used to support the Northern Ireland breast screening programme and help women decide whether to attend breast screening. Translations are of the 2014 version.This is also available in audio format by clicking�here.�

Newborn Hearing Screening (English and translations)

Your baby will be given a series of routine health checks in the first few weeks of life. This will include a hearing screen. The hearing screen uses a quick simple test to check the hearing of all newborn babies. � .

Newborn blood spot screening (English and 10 translations)

The newborn blood spot pre-screening information leaflet for parents has been revised to include information about sickle cell disorders (SCD) and medium chain�acyl coA dehydrogenase deficiency (MCADD) family history. The revised pre-screening leaflet should be given to all pregnant women by 30 weeks gestation and reissued to parents following delivery, before day five.Further information about screening and the care of children with SCD is available at:

The Northern Ireland Breast Screening Programme - Guide for health professionals

This booklet is aimed at GPs and practice managers to enable them to promote informed choice for women invited for breast screening.

Abdominal aortic aneurysm (AAA) screening: Things you need to know (English and translations)

This information leaflet is for all men invited to take part in the Northern Ireland Abdominal Aortic Aneurysm (AAA) Screening Programme. Men will automatically be invited for screening in their 65th year, while men aged over 65 can request a scan through the central screening office.

Breast screening: For women with a higher risk of breast cancer

This leaflet explains breast screening for women with a higher risk of breast cancer.

Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO) Screening Information leaflet

Information for patients being screened for Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO)

Bowel cancer screening: how to take your test (for people who are partially sighted)

This leaflet provides step-by-step instructions on using the Faecal Immunochemical�Test (FIT) for bowel cancer screening. This kit is slightly different to the one we usually use as part of Northern Ireland��'s bowel cancer screening programme. It is easier to complete for people who are partially sighted and is sent following discussion with the screening helpline team.